Literature DB >> 1468518

Selective decontamination in neutropenic patients.

E Kurrle1, T Schmeiser, W Kern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1468518      PMCID： PMC2271936          DOI： 10.1017/s0950268800050329

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


× No keyword cloud information.
  54 in total

1.  Effects of selective oral antimicrobial prophylaxis and systemic antibiotics on the fecal flora and fecal beta-aspartylglycine concentration in patients with acute leukemia.

Authors:  W Bär; G W Welling; E Kurrle
Journal:  APMIS       Date:  1989-08       Impact factor: 3.205

2.  Impact of oral ciprofloxacin on the faecal flora of healthy volunteers.

Authors:  R Enzensberger; P M Shah; H Knothe
Journal:  Infection       Date:  1985 Nov-Dec       Impact factor: 3.553

3.  Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two.

Authors:  E Estey; A Maksymiuk; T Smith; V Fainstein; M Keating; K B McCredie; E J Freireich; G P Bodey
Journal:  Arch Intern Med       Date:  1984-08

4.  Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.

Authors:  W Brumfitt; I Franklin; D Grady; J M Hamilton-Miller; A Iliffe
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

5.  Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.

Authors:  C A Kauffman; M K Liepman; A G Bergman; J Mioduszewski
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

6.  Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.

Authors:  M Rozenberg-Arska; A W Dekker; J Verhoef
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553

7.  Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.

Authors:  J C Wade; C A de Jongh; K A Newman; J Crowley; P H Wiernik; S C Schimpff
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

8.  Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin.

Authors:  M Rozenberg-Arska; A Dekker; L Verdonck; J Verhoef
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

9.  Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial.

Authors:  P A Pizzo; K J Robichaud; B K Edwards; C Schumaker; B S Kramer; A Johnson
Journal:  J Pediatr       Date:  1983-01       Impact factor: 4.406

10.  Effect of oral ciprofloxacin on the faecal flora of healthy volunteers.

Authors:  H A Holt; D A Lewis; L O White; S Y Bastable; D S Reeves
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267
View more
  1 in total

1.  Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.

Authors:  Dong Gun Lee; Su Mi Choi; Jung Hyun Choi; Jin Hong Yoo; Yoon Hee Park; Yoo Jin Kim; Seok Lee; Chang Ki Min; Hee Je Kim; Dong Wook Kim; Jong Wook Lee; Woo Sung Min; Wan Shik Shin; Chun Choo Kim
Journal:  Korean J Intern Med       Date:  2002-03       Impact factor: 2.884
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.